ERV3-1 and ovarian carcinoma: Remarkably, antibodies against HERV Env proteins, including anti-ERV3 (30%), anti-HERV-E (40%), and anti-HERV-K (55%), were detected in the serum of patients with ovarian cancer, but not in healthy controls.